Please contact Scott Hall at firstname.lastname@example.org or 202-463-5817.
TRIPS Council: Discussion Of IP And Innovation Irritates India: Other Issues Unchanged
Global Innovation Policy Center @globalIPcenter 10h
“Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.” https://t.co/UE6nqe8Cyb